 | • レポートコード：MRC2207A075 • 出版社/出版日：Transparency Market Research / 2022年5月 • レポート形態：英文、PDF、243ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トランスペアレンシー・マーケット・リサーチ社の本調査レポートでは、世界の血管グラフト市場について総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品タイプ別（血管内ステントグラフト、末梢血管グラフト、血液透析アクセスグラフト、バイパスグラフト、その他）分析、原料別分析、用途別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容をまとめております。なお、本書に掲載されている企業情報にはLaMaitre Vascular, Inc.、B. Braun Melsungen AG、C. R. Bard, Inc.、Cook Medical、Medtronic plc、ArteGrafts, Inc.、Vascutek Ltd.、Vascular Grafts Solution Ltd.、Heart Medical Europe BV、W. L. Gore & Associates, Inc.などが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の血管グラフト市場規模：製品タイプ別（血管内ステントグラフト、末梢血管グラフト、血液透析アクセスグラフト、バイパスグラフト、その他） ・世界の血管グラフト市場規模：原料別 ・世界の血管グラフト市場規模：用途別 ・世界の血管グラフト市場規模：エンドユーザー別 ・世界の血管グラフト市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Vascular Graft Market – Scope of Report
TMR’s report on the global vascular graft market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global vascular graft market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vascular graft market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the vascular graft market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global vascular graft market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global vascular graft market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global vascular graft market.
The report delves into the competitive landscape of the global vascular graft market. Key players operating in the global vascular graft market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global vascular graft market profiled in this report.
Research Methodology
The research methodology is a combination of exhaustive primary and secondary researches to analyze the global vascular graft market.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically referred to include, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on an ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
Primary participants included, but are not limited to:
Vascular Graft Solution Ltd.
B. Braun Melsungen AG
Cook Medical
LeMaitre Vascular, Inc.
Others
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we used modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, opportunities prevailing in the market, and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country wise surgery data are the other pivotal factors considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vascular Graft Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vascular Graft Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Top 3 players operating in the market space
5.4. COVID-19 Impact Analysis
6. Global Vascular Graft Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Endovascular Stent Graft
6.3.2. Peripheral Vascular Graft
6.3.3. Hemodialysis Access Graft
6.3.4. Bypass Graft
6.3.5. Others
6.4. Market Attractiveness Analysis, By Product Type
7. Global Vascular Graft Market Analysis and Forecast, By Source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Source, 2017–2031
7.3.1. Synthetic
7.3.1.1. Polytetrafluethylene (PTFE)
7.3.1.2. Polyurethane (PU)
7.3.1.3. Dacron
7.3.1.4. Others
7.3.2. Biological
7.3.2.1. Bovine Vein
7.3.2.2. Saphenous Vein
7.3.2.3. Others
7.3.3. Biosynthetic
7.3.3.1. Ovine Collagen with Polyester
7.3.3.2. Others
7.4. Market Attractiveness Analysis, By Source
8. Global Vascular Graft Market Analysis and Forecast, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Coronary Artery Disease
8.3.2. Aneurysm
8.3.3. Vascular Occlusion
8.3.4. Renal Failure
8.3.5. Others
8.4. Market Attractiveness Analysis, By Application
9. Global Vascular Graft Market Analysis and Forecast, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Cardiac Catheterization Laboratories
9.3.4. Specialty Clinics
9.3.5. Others
9.4. Market Attractiveness Analysis, By End-user
10. Global Vascular Graft Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Country/Region
11. North America Vascular Graft Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Endovascular Stent Graft
11.2.2. Peripheral Vascular Graft
11.2.3. Hemodialysis Access Graft
11.2.4. Bypass Graft
11.2.5. Others
11.3. Market Value Forecast, by Source, 2017–2031
11.3.1. Synthetic
11.3.1.1. Polytetrafluethylene (PTFE)
11.3.1.2. Polyurethane (PU)
11.3.1.3. Dacron
11.3.1.4. Others
11.3.2. Biological
11.3.2.1. Bovine Vein
11.3.2.2. Saphenous Vein
11.3.2.3. Others
11.3.3. Biosynthetic
11.3.3.1. Ovine Collagen with Polyester
11.3.3.2. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Coronary Artery Disease
11.4.2. Aneurysm
11.4.3. Vascular Occlusion
11.4.4. Renal Failure
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Cardiac Catheterization Laboratories
11.5.4. Specialty Clinics
11.5.5. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Source
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Vascular Graft Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Endovascular Stent Graft
12.2.2. Peripheral Vascular Graft
12.2.3. Hemodialysis Access Graft
12.2.4. Bypass Graft
12.2.5. Others
12.3. Market Value Forecast, by Source, 2017–2031
12.3.1. Synthetic
12.3.1.1. Polytetrafluethylene (PTFE)
12.3.1.2. Polyurethane (PU)
12.3.1.3. Dacron
12.3.1.4. Others
12.3.2. Biological
12.3.2.1. Bovine Vein
12.3.2.2. Saphenous Vein
12.3.2.3. Others
12.3.3. Biosynthetic
12.3.3.1. Ovine Collagen with Polyester
12.3.3.2. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Coronary Artery Disease
12.4.2. Aneurysm
12.4.3. Vascular Occlusion
12.4.4. Renal Failure
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Cardiac Catheterization Laboratories
12.5.4. Specialty Clinics
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Source
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Vascular Graft Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Endovascular Stent Graft
13.2.2. Peripheral Vascular Graft
13.2.3. Hemodialysis Access Graft
13.2.4. Bypass Graft
13.2.5. Others
13.3. Market Value Forecast, by Source, 2017–2031
13.3.1. Synthetic
13.3.1.1. Polytetrafluethylene (PTFE)
13.3.1.2. Polyurethane (PU)
13.3.1.3. Dacron
13.3.1.4. Others
13.3.2. Biological
13.3.2.1. Bovine Vein
13.3.2.2. Saphenous Vein
13.3.2.3. Others
13.3.3. Biosynthetic
13.3.3.1. Ovine Collagen with Polyester
13.3.3.2. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Coronary Artery Disease
13.4.2. Aneurysm
13.4.3. Vascular Occlusion
13.4.4. Renal Failure
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Cardiac Catheterization Laboratories
13.5.4. Specialty Clinics
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Source
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Vascular Graft Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Endovascular Stent Graft
14.2.2. Peripheral Vascular Graft
14.2.3. Hemodialysis Access Graft
14.2.4. Bypass Graft
14.2.5. Others
14.3. Market Value Forecast, by Source, 2017–2031
14.3.1. Synthetic
14.3.1.1. Polytetrafluethylene (PTFE)
14.3.1.2. Polyurethane (PU)
14.3.1.3. Dacron
14.3.1.4. Others
14.3.2. Biological
14.3.2.1. Bovine Vein
14.3.2.2. Saphenous Vein
14.3.2.3. Others
14.3.3. Biosynthetic
14.3.3.1. Ovine Collagen with Polyester
14.3.3.2. Others
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Coronary Artery Disease
14.4.2. Aneurysm
14.4.3. Vascular Occlusion
14.4.4. Renal Failure
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Cardiac Catheterization Laboratories
14.5.4. Specialty Clinics
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Source
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Vascular Graft Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Endovascular Stent Graft
15.2.2. Peripheral Vascular Graft
15.2.3. Hemodialysis Access Graft
15.2.4. Bypass Graft
15.2.5. Others
15.3. Market Value Forecast, by Source, 2017–2031
15.3.1. Synthetic
15.3.1.1. Polytetrafluethylene (PTFE)
15.3.1.2. Polyurethane (PU)
15.3.1.3. Dacron
15.3.1.4. Others
15.3.2. Biological
15.3.2.1. Bovine Vein
15.3.2.2. Saphenous Vein
15.3.2.3. Others
15.3.3. Biosynthetic
15.3.3.1. Ovine Collagen with Polyester
15.3.3.2. Others
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Coronary Artery Disease
15.4.2. Aneurysm
15.4.3. Vascular Occlusion
15.4.4. Renal Failure
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Cardiac Catheterization Laboratories
15.5.4. Specialty Clinics
15.5.5. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Source
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2020
16.3. Company Profiles
16.3.1. LaMaitre Vascular, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. B. Braun Melsungen AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. C. R. Bard, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. Cook Medical
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Medtronic plc
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. ArteGrafts, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Vascutek Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. Vascular Grafts Solution Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview
16.3.9. Heart Medical Europe BV
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. W. L. Gore & Associates, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview
Table 01: Global Vascular Graft Market Size (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Vascular Graft Market Size (US$ Mn) Forecast, by Source, 2017–2031
Table 03: Global Vascular Graft Market Size (US$ Mn) Forecast, by Synthetic, 2017–2031
Table 04: Global Vascular Graft Market Size (US$ Mn) Forecast, by Biological, 2017–2031
Table 05: Global Vascular Graft Market Size (US$ Mn) Forecast, by Biosynthetic, 2017–2031
Table 06: Global Vascular Graft Market Size (US$ Mn) Forecast, by Size of Vascular Graft, 2017–2031
Table 07: Global Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: Global Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Global Vascular Graft Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 10: North America Vascular Graft Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 11: North America Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 12: North America Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017–2031
Table 13: North America Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031
Table 14: North America Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017–2031
Table 15: North America Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017–2031
Table 16: North America Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017–2031
Table 17: North America Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: North America Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 21: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017–2031
Table 22: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031
Table 23: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017–2031
Table 24: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017–2031
Table 25: Europe Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017–2031
Table 26: Europe Vascular Graft Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 27: Europe Vascular Graft Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 28: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 29: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 30: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017–2031
Table 31: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031
Table 32: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017–2031
Table 33: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017–2031
Table 34: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017–2031
Table 35: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 36: Asia Pacific Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 37: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 38: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 39: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017–2031
Table 40: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031
Table 41: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017–2031
Table 42: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic Source, 2017–2031
Table 43: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017–2031
Table 44: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 45: Latin America Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 46: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 47: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 48: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by Source, 2017–2031
Table 49: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031
Table 50: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by Biological, 2017–2031
Table 51: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by Biosynthetic, 2017–2031
Table 52: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by Size of Vascular Graft, 2017–2031
Table 53: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 54: Middle East & Africa Vascular Graft Market Value (US$ Mn) Forecast, by End-user, 2017–2031